Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03619837
What this trial is testing

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Who this might be right for
Hepatitis CTransplantation Disease Transmission
University of California, San Francisco 122
Testing effectiveness (Phase 2)Study completedNCT04311632
What this trial is testing

A Dose Escalation Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 13
Post-approval studies (Phase 4)Study completedNCT05152628
What this trial is testing

Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Who this might be right for
Liver TransplantationKidney Transplantation
Astellas Pharma China, Inc. 55
Testing effectiveness (Phase 2)Study completedNCT02921789
What this trial is testing

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationPrimary Focal Segmental Glomerulosclerosis (FSGS)
Astellas Pharma Global Development, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Study completedNCT01817322
What this trial is testing

Kidney Graft Function Under the Immunosuppression Strategies

Who this might be right for
Chronic Renal Disease
Samsung Medical Center 140
Testing effectiveness (Phase 2)Study completedNCT00239902
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 396
Post-approval studies (Phase 4)Study completedNCT00154297
What this trial is testing

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 139
Testing effectiveness (Phase 2)Looking for participantsNCT04005469
What this trial is testing

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Who this might be right for
Ischemia Reperfusion InjuryDelayed Graft Function
Rhode Island Hospital 20
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT00238940
What this trial is testing

Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants

Who this might be right for
Renal Transplantation
Novartis 55
Post-approval studies (Phase 4)Study completedNCT01742624
What this trial is testing

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

Who this might be right for
de Novo Kidney Transplantation
Astellas Pharma Korea, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00765661
What this trial is testing

Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients

Who this might be right for
Kidney FailureRenal Failure
Veloxis Pharmaceuticals 63
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Not applicableStudy completedNCT01672957
What this trial is testing

An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 128
Not applicableStudy completedNCT06425497
What this trial is testing

DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY

Who this might be right for
Kidney Transplant; ComplicationsImmunosuppression
University of Rome Tor Vergata 600
Post-approval studies (Phase 4)Study completedNCT00492661
What this trial is testing

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus

Who this might be right for
Renal TransplantionKidney Transplantion
Janssen-Cilag Pty Ltd 55
Post-approval studies (Phase 4)Study completedNCT03076151
What this trial is testing

Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation

Who this might be right for
TransplantationKidneyPharmacokinetic
University Hospital, Limoges 30
Post-approval studies (Phase 4)UnknownNCT00159159
What this trial is testing

LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant

Who this might be right for
Cardiac Transplantion
Hospices Civils de Lyon 106
Large-scale testing (Phase 3)Study completedNCT00170833
What this trial is testing

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 80
Next Page